johnson & johnson

johnson & johnson

Displaying 10 out of 33 results

  1. The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

    Bayer stresses drug's tolerability in bid for prostate cancer market

    Bayer is banking on the mild side effects of its experimental prostate cancer drug darolutamide, as it prepares to take on established rival ...
  2. FILE PHOTO: A bottle of Johnson's Baby Powder is seen in a photo illustration taken in New York

    Johnson & Johnson supplier seeks bankruptcy over talc lawsuits

    A key supplier of talc used in Johnson & Johnson's baby powder filed for Chapter 11 bankruptcy on Wednesday in the wake of multibillion-dollar ...
  3. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    Johnson & Johnson to buy surgical robotics firm Auris for US$3.4 billion

    Healthcare conglomerate Johnson & Johnson said on Wednesday it would buy privately held surgical robotics company Auris Health Inc for about ...
  4. A Johnson & Johnson building is shown in Irvine, California

    US FDA panel recommends approval of Johnson & Johnson's depression drug

    An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson & Johnson's experimental nasal spray, which has a ...
  5. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    J&J becomes first drugmaker to add prices to television ads

    Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first ...
  6. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    US senator asks J&J for documents on talc, baby powder safety

    U.S. Democratic Senator Patty Murray sent a letter to Johnson & Johnson on Tuesday seeking information related to allegations in a Reuters Special ...
  7. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    J&J, US states settle hip implant claims for US$120 million

    Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay US$120 million to resolve deceptive marketing claims by several U.S. states ...
  8. A Johnson & Johnson building is shown in Irvine, California

    Johnson & Johnson 2019 revenue forecast misses expectations

    Johnson & Johnson reported better-than-expected fourth-quarter revenue on Tuesday, helped by strong demand for its drugs to treat cancer and ...
  9. FILE PHOTO:  A Johnson & Johnson building is shown in Irvine, California

    Johnson & Johnson raises US prices on around two dozen drugs